You have 9 free searches left this month | for more free features.

Condition

Retinitis Pigmentosa (3)

Glaucoma (1)

Usher Syndrome Type 2 (1)

Usher Syndrome Type 3 (1)

Overall Status

Completed (3)

Recruiting (1)

Sign in for free

Phase

phase 2 (4)

Sponsor

Neurotech Pharmaceuticals (3)

Stanford University (1)

Collaborator

FDA Office of Orphan Products Development (1)

University of California, San Francisco (1)

Intervention

nt-501 (4)

sham (1)

sham comparator (1)

Study Documents

Intervention Type

drug (4)

other (1)

procedure (1)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

nt-501

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glaucoma Trial in Palo Alto (NT-501, Sham comparator)

Recruiting

Glaucoma

NT-501
Sham comparator

Palo Alto, California

Byers Eye Institute at Stanford University

Aug 13, 2021

Retinitis Pigmentosa, Usher Syndrome Type 2, Usher Syndrome Type 3 Trial in San Francisco (NT-501, Sham)

Completed

Retinitis Pigmentosa
+2 more

NT-501
Sham

San Francisco, California

University of California, San Francisco

Apr 14, 2022

Retinitis Pigmentosa Trial in United States (NT-501)

Completed

Retinitis Pigmentosa

NT-501

Beverly Hills, California
+11 more

Nov 15, 2016

Retinitis Pigmentosa Trial in United States (NT-501)

Completed

Retinitis Pigmentosa

NT-501

Beverly Hills, California
+12 more

Nov 15, 2016